A citation-based method for searching scientific literature

T L Stevens, J C Burnett, M Kinoshita, Y Matsuda, M M Redfield. J Clin Invest 1995
Times Cited: 98







List of co-cited articles
925 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Atrial natriuretic peptide elevation in congestive heart failure in the human.
J C Burnett, P C Kao, D C Hu, D W Heser, D Heublein, J P Granger, T J Opgenorth, G S Reeder. Science 1986
915
33


Natriuretic peptide system in human heart failure.
C M Wei, D M Heublein, M A Perrella, A Lerman, R J Rodeheffer, C G McGregor, W D Edwards, H V Schaff, J C Burnett. Circulation 1993
365
22


Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction.
M M Redfield, L L Aarhus, R S Wright, J C Burnett. Circulation 1993
71
28

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
20


Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
J L Rouleau, M A Pfeffer, D J Stewart, D Isaac, F Sestier, E K Kerut, C B Porter, G Proulx, C Qian, A J Block. Lancet 2000
323
16

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur,[...]. N Engl J Med 2000
699
15


Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.
M J Lopez, S K Wong, I Kishimoto, S Dubois, V Mach, J Friesen, D L Garbers, A Beuve. Nature 1995
393
14

Effects of synthetic atrial natriuretic factor on renal function and renin release.
J C Burnett, J P Granger, T J Opgenorth. Am J Physiol 1984
731
13

ANF-mediated renal cGMP generation in congestive heart failure.
K B Margulies, D M Heublein, M A Perrella, J C Burnett. Am J Physiol 1991
81
16


Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
H Yasue, M Yoshimura, H Sumida, K Kikuta, K Kugiyama, M Jougasaki, H Ogawa, K Okumura, M Mukoyama, K Nakao. Circulation 1994
13

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
K Yamamoto, J C Burnett, M Jougasaki, R A Nishimura, K R Bailey, Y Saito, K Nakao, M M Redfield. Hypertension 1996
452
12

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.
S W John, J H Krege, P M Oliver, J R Hagaman, J B Hodgin, S C Pang, T G Flynn, O Smithies. Science 1995
498
12


Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
R J Cody, S A Atlas, J H Laragh, S H Kubo, A B Covit, K S Ryman, A Shaknovich, K Pondolfino, M Clark, M J Camargo. J Clin Invest 1986
774
11

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.
P M Oliver, J E Fox, R Kim, H A Rockman, H S Kim, R L Reddick, K N Pandey, S L Milgram, O Smithies, N Maeda. Proc Natl Acad Sci U S A 1997
464
11

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
A Lerman, R J Gibbons, R J Rodeheffer, K R Bailey, L J McKinley, D M Heublein, J C Burnett. Lancet 1993
291
10

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
10

Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
T Supaporn, S M Sandberg, D D Borgeson, D M Heublein, A Luchner, C M Wei, T P Dousa, J C Burnett. Kidney Int 1996
67
14

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure.
S S Gottlieb, M L Kukin, D Ahern, M Packer. J Am Coll Cardiol 1989
326
10

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.
M Yoshimura, H Yasue, E Morita, N Sakaino, M Jougasaki, M Kurose, M Mukoyama, Y Saito, K Nakao, H Imura. Circulation 1991
407
10

Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
H H Chen, J A Schirger, W L Chau, M Jougasaki, O Lisy, M M Redfield, P T Barclay, J C Burnett. Circulation 1999
55
18



Diverse biological actions of atrial natriuretic peptide.
B M Brenner, B J Ballermann, M E Gunning, M L Zeidel. Physiol Rev 1990
889
10

Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.
M Volpe, C Tritto, N De Luca, A F Mele, G Lembo, S Rubattu, M Romano, P De Campora, I Enea, B Ricciardelli. J Clin Invest 1991
71
12




A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
9

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.
H H Chen, J A Grantham, J A Schirger, M Jougasaki, M M Redfield, J C Burnett. J Am Coll Cardiol 2000
60
15

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
471
9


Biochemical detection of left-ventricular systolic dysfunction.
T A McDonagh, S D Robb, D R Murdoch, J J Morton, I Ford, C E Morrison, H Tunstall-Pedoe, J J McMurray, H J Dargie. Lancet 1998
796
8

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
240
8


Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.
T A McDonagh, C E Morrison, A Lawrence, I Ford, H Tunstall-Pedoe, J J McMurray, H J Dargie. Lancet 1997
456
8

Atrial natriuretic peptide in heart failure.
R R Brandt, R S Wright, M M Redfield, J C Burnett. J Am Coll Cardiol 1993
67
11


Angiotensin II in the evolution of experimental heart failure.
A Luchner, T L Stevens, D D Borgeson, M M Redfield, J E Bailey, S M Sandberg, D M Heublein, J C Burnett. Hypertension 1996
55
14



Atrial natriuretic peptide and sodium homeostasis in compensated heart failure.
T E Lohmeier, H L Mizelle, G A Reinhart, J P Montani, C E Hord, R H Didlake. Am J Physiol 1996
10
80


Renal actions of synthetic dendroaspis natriuretic peptide.
O Lisy, M Jougasaki, D M Heublein, J A Schirger, H H Chen, P W Wennberg, J C Burnett. Kidney Int 1999
83
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.